Lupin, Takeda in pact to market gastric drug in India; stock slips.
Global pharmaceutical company Lupin Limited has entered into a non-exclusive patent licence agreement with Takeda Pharmaceutical Company Limited to commercialise
Continue readingThe Number One Finance & Business Blog!
Global pharmaceutical company Lupin Limited has entered into a non-exclusive patent licence agreement with Takeda Pharmaceutical Company Limited to commercialise
Continue readingFor this quarter, global API sales reached Rs 362.2 crore, marking a 40.3 per cent increase from Q4 FY24. This
Continue readingFitch Ratings has revised the outlook on India-based Tata Steel Ltd’s (TSL) Issuer Default Rating (IDR) to Negative, from Stable,
Continue readingDrugmaker Lupin and a unit of Aurobindo Pharma are recalling products from the American market due to manufacturing issues. 2
Continue reading1 min read Last Updated : Jun 17 2024 | 8:42 PM IST Global pharmaceutical company Lupin announced today
Continue readingTraditional Indian jewellery is getting a makeover. (File photo) 2 min read Last Updated : May 09 2024 | 1:34
Continue readingGHCL has announced a capital budget of approximately ₹224 crore for the financial year 2024-25, including a Bromine Project of
Continue readingTata Steel will invest £1.25 billion to build a modern electric arc furnace in Port Talbot and commence closure of
Continue readingDrug maker Lupin on Friday said it has received approval from the US health regulator to market a generic
Continue readingNorth America sales for Q3 FY 2024 were Rs 1,888.5 crore, up 23.7 per cent Y-o-Y. North America accounted for
Continue reading